Predict your next investment

HEALTHCARE | Medical Devices & Equipment
refractec.com

See what CB Insights has to offer

Executives

1

Board of Directors

1

Refractec Board of Director

1 Board of directors

Refractec has 1 board of directors, including William Link.

Name

Firm

Work History

Other Seats

William Link

Bill Link is a Managing Director specializing in early-stage investing in medical devices at Versant. Prior to co-founding Versant Ventures, Bill was a general partner at Brentwood Venture Capital. With more than two decades of operations experience in the healthcare industry, he has a proven record of building and managing large, successful medical product companies. His extensive knowledge of medical devices, particularly in ophthalmology, has contributed to Versant’s recognized leadership in this specialty area. Perhaps Bill’s greatest operational success was as founder, chairman and CEO of Chiron Vision, a subsidiary of Chiron Corporation specializing in ophthalmic surgical products, which was sold to Bausch and Lomb in 1997. Prior to Chiron Vision, Bill founded and served as President of American Medical Optics (AMO), a division of American Hospital Supply Corporation, which was sold to Allergan in 1986. Later Bill served on the Board of AMO’s successor company, Advanced Medical Optics (AMO) which was acquired by Abbott in 2009. Before entering the healthcare industry, Bill was an Assistant Professor in the Department of Surgery at the Indiana University School of Medicine.

Cameron Health, Edwards Lifesciences, FeRx, ForSight Vision2, Forsight VISION5, Glaukos, Inogen, LenSx Lasers, NeoVista, Nexis Vision, Oculeve, and OraMetrix

Name

William Link

Firm

Work History

Bill Link is a Managing Director specializing in early-stage investing in medical devices at Versant. Prior to co-founding Versant Ventures, Bill was a general partner at Brentwood Venture Capital. With more than two decades of operations experience in the healthcare industry, he has a proven record of building and managing large, successful medical product companies. His extensive knowledge of medical devices, particularly in ophthalmology, has contributed to Versant’s recognized leadership in this specialty area. Perhaps Bill’s greatest operational success was as founder, chairman and CEO of Chiron Vision, a subsidiary of Chiron Corporation specializing in ophthalmic surgical products, which was sold to Bausch and Lomb in 1997. Prior to Chiron Vision, Bill founded and served as President of American Medical Optics (AMO), a division of American Hospital Supply Corporation, which was sold to Allergan in 1986. Later Bill served on the Board of AMO’s successor company, Advanced Medical Optics (AMO) which was acquired by Abbott in 2009. Before entering the healthcare industry, Bill was an Assistant Professor in the Department of Surgery at the Indiana University School of Medicine.

Other Seats

Cameron Health, Edwards Lifesciences, FeRx, ForSight Vision2, Forsight VISION5, Glaukos, Inogen, LenSx Lasers, NeoVista, Nexis Vision, Oculeve, and OraMetrix

Refractec Management Team

1 Team Member

Refractec has 1 executive. Refractec's former Chief Executive Officer, President is Mitchell B Campbell.

Name

Work History

Title

Status

Mitchell B Campbell

Chief Executive Officer, President

Former

Name

Mitchell B Campbell

Work History

Title

Chief Executive Officer, President

Status

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.